Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Postmarketing Visicol study begins patient treatment

April 8, 2003

Hepavir B enters clinical testing

April 8, 2003

Effects of etiprednol dicloacetate on the HPA axis

April 8, 2003

Remicade approved for long-term use in fistulizing Crohn's disease

April 7, 2003

N,N-Disubstituted phenylalanines with potent, selective activity against HCV NS5B polymerase

April 4, 2003

Topline results for alvimopan phase III study

April 4, 2003

AstraZeneca seeks approval for Nexium in NSAID-associated upper GI symptoms

April 3, 2003

Novartis acquires majority stake in Idenix

April 2, 2003

H+/K+-ATPase inhibitors and their use described by AstraZeneca researchers

April 2, 2003

Novel gastric antisecretory drugs under study at Altana Pharma

March 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...